Lung Cancer: treatments, trials & survival
Lung cancer is the leading cause of cancer death in the US. Explore current treatment advances, immunotherapy breakthroughs, and available clinical trials.
About Lung Cancer
Lung cancer is the leading cause of cancer death in the US. Explore current treatment advances, immunotherapy breakthroughs, and available clinical trials.
According to the National Cancer Institute’s SEER database, an estimated 234,580 new cases of lung cancer will be diagnosed in the United States in 2024, with approximately 125,070 deaths. The overall 5-year relative survival rate is 25.4%.
Treatment options
Current treatment approaches for lung cancer depend on the stage at diagnosis, tumor characteristics, and the patient’s overall health. The most common options include:
Treatment recommendations should always be discussed with a qualified oncologist. The options listed above are based on current clinical guidelines and may vary case by case.
Stages
Staging describes the extent of cancer in the body and is crucial for planning the most appropriate treatment:
Known risk factors
Understanding risk factors can support prevention and early detection. Known risk factors for this cancer include:
Active clinical trials
Clinical trials offer access to cutting-edge treatments not yet widely available. The trials below are sourced in real time from ClinicalTrials.gov:
Frequently asked questions
Looking for lung cancer treatment options?
A patient navigator can help you explore treatment pathways, find clinical trials near you, and connect with specialists who see lung cancer every day. Free, confidential consultation.
Talk to a navigator
Leave your details and we’ll call you at your preferred time.